TESSERA DEFENSE AND HOMELAND
HLSQNYSE AMERICAN๐ #5323 by market capUS Equity
โโ
Quote unavailableTrack HLSQ
Get earnings, price moves & breaking news on Telegram
24hโ
7dโ
14dโ
30dโ
ytdโ
1yโ
๐ฆMarket Cap
$467,924
Small Cap
๐Revenue Growth (YoY)
โ
๐Gross Margin
โ
๐ตFCF Margin
โ
โ๏ธP/S Ratio
โ
Otter Score
โ
Insufficient data
No chart data available for HLSQ.
Trading Snapshot
- Day Range
- โ
- 52-Week Range
- $0.02 โ $1.75
- Volume (shares)
- โ
- Avg Volume (shares)
- โ
- Shares Outstanding
- 26.0M
- Next Earnings
- โ
Fundamentals Snapshot
- Annual Revenue
- โ
- Last Q Revenue
- $332,000
- P/E Ratio
- โ
- P/S Ratio
- โ
- EPS (TTM)
- $-21.44
- Dividend Yield
- โ
TESSERA DEFENSE AND HOMELAND
HLSQFinancial Trends
Financial history unavailable.
About TESSERA DEFENSE AND HOMELAND
Tessera Defense & Homeland Security, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Dover, DE.
๐ฆฆ
Otter Score Breakdown
How it's scoredFive components, each rated 1โ5โ and equally weighted (20%), averaged to a 0โ100 score:๐ Quality โ gross margin๐ Growth โ revenue YoYโ๏ธ Valuation โ P/S ratioโก Momentum โ 30-day price change๐ง Dilution โ 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Overall Score
Insufficient data
โ/100
Analyst data unavailable.
Latest News & Updates
News unavailable.